EP Patent

EP0429987A2 — 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection

Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 1991-06-05 · 35y expired

What this patent protects

Disclosed are novel 5,11-dihydro-6H-dipyrido[3,2-b; 2',3'-e][1,4]diazepines of formula wherein, Z is oxygen, sulfur, =NCN or a group of the formula =NOR⁹. These compounds are useful in the prevention or treatment of HIV infection.

USPTO Abstract

Disclosed are novel 5,11-dihydro-6H-dipyrido[3,2-b; 2',3'-e][1,4]diazepines of formula wherein, Z is oxygen, sulfur, =NCN or a group of the formula =NOR⁹. These compounds are useful in the prevention or treatment of HIV infection.

Drugs covered by this patent

Patent Metadata

Patent number
EP0429987A2
Jurisdiction
EP
Classification
—
Expires
1991-06-05
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.